{
    "2019-08-01": [
        [
            {
                "time": "",
                "original_text": "【天风医药】行业点评：高值医用耗材改革方案落地，行业规范程度提升",
                "features": {
                    "keywords": [
                        "高值医用耗材",
                        "改革方案",
                        "行业规范"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "科创板首例，容百科技8亿投资理财！为何近1000家公司7351亿不投主业？",
                "features": {
                    "keywords": [
                        "科创板",
                        "容百科技",
                        "投资理财",
                        "主业"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2019国家技术创新示范企业榜上有哪些药企的身影？",
                "features": {
                    "keywords": [
                        "技术创新",
                        "示范企业",
                        "药企"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药生物创新药】行业研究报告：政策&市场-拥抱变革·制胜创新之一：顾盼大分子市场",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "政策",
                        "市场",
                        "大分子市场"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-08-01",
                "original_text": "最新公告透露利好 13只个股有望爆发（08.01）",
                "features": {
                    "keywords": [
                        "公告",
                        "利好",
                        "个股爆发"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药获《临床试验通知书》",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "临床试验",
                        "通知书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:中药保护申请16项证明事项取消",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中药保护",
                        "证明事项取消"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}